The potential use of toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents
Author:
Publisher
Informa UK Limited
Subject
Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy
Link
http://www.tandfonline.com/doi/pdf/10.1080/08923970902802926
Reference35 articles.
1. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
2. Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors
3. Therapeutic targeting of pattern-recognition receptors
4. Immunobiology of Toll‐like receptors: Emerging trends
5. Targeting toll‐like receptors for drug development: a summary of commercial approaches
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Endosomal Toll-Like Receptors intermediate negative impacts of viral diseases, autoimmune diseases, and inflammatory immune responses on the cardiovascular system;Expert Review of Clinical Immunology;2024-08-20
2. From defense to offense: Modulating toll-like receptors to combat arbovirus infections;Human Vaccines & Immunotherapeutics;2024-01-23
3. The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management;Medicinal Research Reviews;2024-01-16
4. Exploring TLR signaling pathways as promising targets in cervical cancer: The road less traveled;International Review of Cell and Molecular Biology;2024
5. Network-Based In Silico Analysis of New Combinations of Modern Drug Targets with Methotrexate for Response-Based Treatment of Rheumatoid Arthritis;Journal of Personalized Medicine;2023-10-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3